Associate Director
vor 2 Wochen
**Associate Director (gn) DMPK**:
- At MorphoSys, our ambition is to redefine how cancer is treated. As a global, commercial-stage biopharmaceutical company, we are driven by the urgency to discover, develop, and deliver groundbreaking medicines, aspiring to give more life for people with cancer.
- Our success is created by our people and we bring together exceptional talent from around the world. We are an equal opportunity employer and take pride in offering our colleagues an open, flexible, and diverse work environment. We are looking for people who share our values and are motivated to improve the lives of people impacted by cancer.-
**Your Responsibilities**:
- Representing DMPK on small and large molecule research program teams
- Responsible for in vitro ADME and animal PK study design and execution, data analysis and PK/PD correlation analysis
- Designing, implementing, driving, and monitoring program related DMPK strategies
- Closely collaborating with internal teams and external partners to execute discovery and development program team objectives
- Interacting with internal bioanalytical team members as well as CROs for the development, transfer and validation of bioanalytical assays
- Contributing to regulatory documents and leading the resolution of ADME and non-clinical PK queries from drug regulatory agencies
- Option to develop into the role of a Clinical Pharmacologist
**Job Qualifications**:
- PhD in Pharmaceutical Sciences, or related field required
- A minimum of 5 years’ experience in the biopharma industry in a DMPK role and proven ability to represent DMPK on project teams and with external partners
- Experience partnering with Clinical Pharmacology, CMC, Translational Science and Discovery colleagues to ensure relevant PK/PD and DMPK strategy is developed
- Ideally experience with IND or CTA submissions and regulatory interactions
- Excellent communication and organizational skills and attention to detail
- Strong time management skills and ability to prioritize multiple tasks efficiently
**We offer**:
- Creative working in X-functional teams
- Open and appreciative corporate culture
- Multicultural environment
- Working in an attractive, high-quality equipped building with restaurant
- Free sports and language courses
- MorphoSys AG, Semmelweisstraße 7, 82152 Planegg
-
Associate Director Operational Excellence
vor 1 Woche
Planegg, Deutschland Tubulis GmbH Vollzeit**Be part of our team**: We are seeking a highly experienced Associate Director of Operational Excellence (GCP) to lead continuous improvement efforts across our clinical trial operations and ensure adherence to the highest standards of GCP compliance. The position will be within the Quality Assurance (QA) department. **Your mission**: - Lead strategic...
-
Associate Medical Director/Medical Director
Vor 5 Tagen
Planegg (Germany), Remote (Germany) Tubulis Vollzeit 80.000 € - 120.000 € pro JahrBe part of our team As an Associate Medical Director/Medical Director and member of our Clinical Development team, you will support the planning and execution of full life-cycle development of our antibody-drug conjugates (ADCs) global clinical trials. You will lead all clinical aspects of clinical trials, provide support to the Clinical Trial Team (CTT),...
-
Associate Director Operational Excellence
Vor 5 Tagen
Planegg (Germany), Remote (Germany) Tubulis Vollzeit 80.000 € - 120.000 € pro JahrBe part of our team We are seeking a highly experienced Associate Director of Operational Excellence (GCP) to lead continuous improvement efforts across our clinical trial operations and ensure adherence to the highest standards of GCP compliance. The position will be within the Quality Assurance (QA) department. We are a dedicated QA team supporting our...
-
Biologist As Clinical Trial Associate
vor 1 Woche
Planegg, Deutschland CatalYm GmbH Vollzeit**About us**: CatalYm is a biotech company based in Martinsried near Munich, developing innovative immunotherapies to transform cancer patients’ lives by effectively engaging their own immune systems to combat this malignant disease. We are now advancing to Phase 2b studies to confirm visugromab, our lead antibody, that has demonstrated durable anti-tumor...